ROCKET PHARMACEUTICALS, INC. (RCKT) Interest Expense USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Rocket Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2014 to 2024.
  • Rocket Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $471 K, a 0.64% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $1.88 M, a 0.64% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. annual Interest Expense for 2023 was $1.88 M, a 0.7% increase from 2022.
  • Rocket Pharmaceuticals, Inc. annual Interest Expense for 2022 was $1.86 M, a 37.5% decline from 2021.
  • Rocket Pharmaceuticals, Inc. annual Interest Expense for 2021 was $2.98 M, a 57.3% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.88 M $471 K +$3 K +0.64% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.88 M $470 K +$2 K +0.43% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $1.87 M $469 K +$4 K +0.86% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.87 M $468 K +$3 K +0.65% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.87 M $468 K +$4 K +0.86% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $1.86 M $468 K +$5 K +1.08% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $1.86 M $465 K -$69 K -12.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $1.93 M $465 K +$214 K +85.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.71 M $464 K -$1.27 M -73.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $2.98 M $463 K -$1.18 M -71.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $4.16 M $534 K -$1.43 M -72.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $5.59 M $251 K -$1.54 M -85.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $7.12 M $1.73 M +$156 K +9.92% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $6.97 M $1.64 M +$297 K +22.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $6.67 M $1.97 M +$501 K +34.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $6.17 M $1.79 M +$242 K +15.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $5.93 M $1.57 M -$31 K -1.93% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $5.96 M $1.34 M -$729 K -35.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $6.69 M $1.47 M +$290 K +24.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $6.4 M $1.54 M +$181 K +13.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $6.22 M $1.6 M +$177 K +12.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $6.04 M $2.07 M +$2.07 M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $3.97 M $1.18 M +$1.18 M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $2.79 M $1.36 M +$1.36 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.43 M $1.43 M +$1.43 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $0 $0 Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 $0 -$525 K -100% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q3 2016 $525 K +$333 K +173% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q4 2015 $1.23 M $0 -$245 K -100% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 $1.48 M $192 K -$52 K -21.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $1.53 M $564 K +$316 K +127% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $1.21 M $474 K +$231 K +95.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 $980 K $245 K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 $244 K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $248 K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $243 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.